IMO favourable ATOMIC-AHF news should add .20 to current SP, (as amgn purchase blunted the impact), COSMIC-HF news will add a gradual $1.00. The orphan Tirasemtive news from the phase IIb BENEFIT-ALS titration study maybe add .20. Hence we are looking at a ~$4 SP near term, prior to phase III studies. Not bad. We enter the fourth inning after ATOMIC-AHF. So play or hold, but dont go away.